The ubiquitin system is one of the central regulators of normal cellular function, and tumor viruses, including Epstein-Barr-Virus (EBV), dysregulate this machinery in the process of cell transformation. We discovered that EBV-dependent transformation of normal human B-cells induces the expression of a ubiquitin-editing enzyme named Ubiquitin C-terminal Hydrolase L1 (UCH L1). Elevated levels of this protein have been observed in many human cancers, and participation of UCH L1 in oncogenesis has become a subject for special attention. Our recent study has demonstrated that the inhibition of UCH L1 expression is required for the transformed status of EBV-transformed B-cells. Preliminary data indicate that EBV products apply distinct mechanisms to activate the uch II promoter in Type II and III of EBV latency. We plan to study the detailed mechanism of EBV-dependent up-regulation of UCH L1 in Aim I.
Aims II and III derive from unexpected discovery made while analyzing the endogenous complexes of UCH L1 in EBV-transformed B-cells that in addition to its monomer, the dimer of UCH L1 also exists in these cells. In contrast to the monomer, which has deubiquitinating activity, the dimer of UCH L1 has been shown to act as a ubiquitin ligase in vitro. We hypothesize that as a ubiquitin-editing enzyme, UCH L1 has opposite functions in cytoplasm and nuclei, and will test this hypothesis in Aims II and III. Additionally, in the context of effects on intercellular signaling in oncogenic pathways, we discovered a positive regulatory feedback between the dimer of UCH L1 and the EBV primary oncogene LMPL This is a first implication of UCH L1 dimer in regulation of tumorigenic signaling in vivo. These studies introduce an unexplored network of regulation that is likely to be relevant not only to EBV but other oncogenic pathways as well.

Public Health Relevance

Ubiquitin-editing enzymes have been implicated in fundamentally important biological processes, including oncogenesis. The studies of this proposal will reveal the functional role of ubiquitin-editing enzyme UCH L1 in EBV-transformed cells and will identify a new therapeutic target in virus-associated malignancies.

Agency
National Institute of Health (NIH)
Type
Research Program Projects (P01)
Project #
5P01CA019014-35
Application #
8686760
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
35
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Anders, Penny; Bhende, Prasanna M; Foote, Michael et al. (2015) Dual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma. Leuk Lymphoma 56:263-6
Giffin, Louise; Damania, Blossom (2014) KSHV: pathways to tumorigenesis and persistent infection. Adv Virus Res 88:111-59
Hosseinipour, Mina C; Sweet, Kristen M; Xiong, Jie et al. (2014) Viral profiling identifies multiple subtypes of Kaposi's sarcoma. MBio 5:e01633-14
Kumar, Ravindra; Whitehurst, Christopher B; Pagano, Joseph S (2014) The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity. J Virol 88:6411-22
Ozgur, Sezgin; Griffith, Jack (2014) Interaction of Kaposi's sarcoma-associated herpesvirus ORF6 protein with single-stranded DNA. J Virol 88:8687-95
Marquitz, Aron R; Mathur, Anuja; Chugh, Pauline E et al. (2014) Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells. J Virol 88:1389-93
Bentz, Gretchen L; Bheda-Malge, Anjali; Wang, Ling et al. (2014) KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation. Virology 448:293-302
Aga, M; Bentz, G L; Raffa, S et al. (2014) Exosomal HIF1? supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes. Oncogene 33:4613-22
Yang, Dongmei; Chen, Wuguo; Xiong, Jie et al. (2014) Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma. Proc Natl Acad Sci U S A 111:E4762-8
Chen, Stefanie Hartman; Plank, Jody L; Willcox, Smaranda et al. (2014) Top3? is required during the convergent migration step of double Holliday junction dissolution. PLoS One 9:e83582

Showing the most recent 10 out of 227 publications